LILLY VENTURES
Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under management and focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.
LILLY VENTURES
Industry:
Financial Services Impact Investing Innovation Management Life Science Venture Capital
Founded:
2001-01-01
Status:
Active
Contact:
(317) 429-0140
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Mimecast Amazon Ohio Region
Similar Organizations
AltsAxis
AltsAxis is a data-driven mobile platform that provides a vast universe of alternative asset managers and social networks.
Koch Disruptive Technologies
Koch Disruptive Technologies is a venture capital firm that invests in technologies to improve businesses and create new opportunities.
Current Employees Featured
Armen Shanafelt General Partner @ Lilly Ventures
General Partner
2014-11-01
Lisa Belas Office Manager @ Lilly Ventures
Office Manager
2009-05-01
Steve Hall Venture Partner @ Lilly Ventures
Venture Partner
2009-05-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-05 | IpiNovyx Bio | Lilly Ventures investment in Seed Round - IpiNovyx Bio | 10 M USD |
| 2020-06-09 | Evox Therapeutics | Lilly Ventures investment in Convertible Note - Evox Therapeutics | 10 M USD |
| 2018-11-13 | Kymera Therapeutics | Lilly Ventures investment in Series B - Kymera Therapeutics | 65 M USD |
| 2018-07-26 | Sutro Biopharma | Lilly Ventures investment in Series E - Sutro Biopharma | 85.4 M USD |
| 2018-06-05 | Nimbus Therapeutics | Lilly Ventures investment in Series C - Nimbus Therapeutics | 65 M USD |
| 2017-10-30 | Kymera Therapeutics | Lilly Ventures investment in Series A - Kymera Therapeutics | 30 M USD |
| 2017-01-06 | Cavion | Lilly Ventures investment in Series A - Cavion | 26.1 M USD |
| 2015-12-01 | Symic Biomedical | Lilly Ventures investment in Series A - Symic Biomedical | 25 M USD |
| 2015-07-16 | Protagonist Therapeutics | Lilly Ventures investment in Series C - Protagonist Therapeutics | 40 M USD |
| 2015-03-23 | Aeglea BioTherapeutics | Lilly Ventures investment in Series B - Aeglea BioTherapeutics | 44 M USD |
Newest Events participated
Participated in Grace Hopper Celebration of Women in Computing 2017
on 2017-10-04 as sponsor
Participated in Biotech and Money London
on 2017-02-07 as sponsor
More informations about "Lilly Ventures"
Learn About Partnering With Lilly - Eli Lilly …
Lilly Catalyze360 Built to engage biotechs at the earliest stages and agnostic of therapeutic area, we offer a global investment arm with Lilly Ventures; lab facilities and scientific …See details»
Lilly Ventures - Investments, Portfolio & Company Exits - Crunchbase
Lilly Ventures 's most notable exits include BioAge Labs, Viracta Therapeutics, and Kymera Therapeutics. Which industries has this organization had the most exits in? Show . BioAge …See details»
Lilly Catalyze360 Comprehensive Approach - Eli Lilly and Company
Lilly Ventures makes investments to move the innovation needle in novel areas of science, extending to health tech, emerging platforms and other impact initiatives. We deploy …See details»
Lilly Ventures - Investor Profile, Portfolio & Team - Tracxn
Dec 2, 2024 Co-investors of Lilly Ventures. Over the past . 23 years, 253 investors have co-invested in Lilly Ventures's portfolio companies.. This includes funds and angels.Invested …See details»
Lilly Ventures investment portfolio - PitchBook
Lilly Ventures's latest investment was on 24-Jul-2023 in basys.ai, a company within the Enterprise Systems (Healthcare) industry. Data Transparency. Meet our data hygiene team. Discover …See details»
Lilly Ventures | MyCapital
Lilly Ventures is the venture capital arm of Eli Lilly and Company, a leading innovation-driven pharmaceutical company. Our primary goal is to facilitate the success of companies in our …See details»
Lilly Ventures - CoBee Company Profile & Funding Rounds
Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of …See details»
Lilly Ventures | Institution Profile - Private Equity International
Lilly Ventures. News, insights, analysis and data. Lilly Ventures overview. Founded in 2002, Lilly Ventures was an Indiana-based arm of Eli Lilly and Company, that invested in life science and …See details»
Lilly Ventures – Investors Database - Unicorn Nest
Lilly Ventures appeared to be a CVC structure as part of the corporation. This organization was formed by Ron Laufer. We also calculated 2 valuable employees in our database. Among the most successful fund investment …See details»
Lilly Ventures Portfolio Investments, Lilly Ventures Funds, Lilly ...
Dec 15, 2003 About Lilly Ventures. Lilly Ventures is the venture capital arm of pharmaceutical company, Eli Lilly. Lilly Ventures will look at early to expansion stage investments. Lilly …See details»
Lilly Ventures Company Profile | Management and Employees List
Lilly Ventures Profile and History. Lilly Ventures has its roots in the scientific tradition of Eli Lilly and Company. Our investment philosophy drives us to seek great companies with compelling …See details»
Lilly Ventures - Funding, Financials, Valuation & Investors
Lilly Ventures has raised a total of $325M across 3 funds, their latest being Lilly Ventures Fund I LLC. This fund was announced on Aug 4, 2009 and raised a total of . obfuscated. obfuscated. …See details»
Becoming an investor - Medium
Jul 22, 2023 My time in operating roles is now paying off in spades as I lead Lilly Ventures’ first Tech investing strategy and advise senior leaders across the organization on opportunities in …See details»
Becoming an investor - by John Pavletic
Jul 22, 2023 My time in operating roles is now paying off in spades as I lead Lilly Ventures’ first Tech investing strategy and advise senior leaders across the organization on opportunities in …See details»
With $200M, Lilly spins out venture biz - Fierce Biotech
Aug 4, 2009 Seeking to operate like traditional venture firms, Lilly Ventures has spun out from Eli Lilly with $200 million in capital financing. Managing Director S. Edward Torres told …See details»
List of top Lilly Ventures Portfolio Companies - Crunchbase
Feb 11, 2005 Lilly Ventures is an Indiana-based venture capital firm that provides investment to companies in the life sciences sector. This list of organizations invested in by Lilly Ventures …See details»
Leadership - Woodbridge
Our Executive Leadership Team brings their vast knowledge and experience together to create a strong and agile organization. Together, they are energizing our global workforce, …See details»
Nicholas Lilly - Senior Director - Inova Blood Donor Services
Liked by Nicholas Lilly. Experience Inova Blood Donor Services 14 years 8 months. Senior Director Inova Blood Donor Services Feb 2023 - Present 1 year 3 months. Director Inova …See details»
Biotech Executive & Venture Fund Founder Lisa Bowers Named …
1 day ago In California, she was the chief commercial officer of Day One Bio, a public biotech company dedicated to pediatric oncology. Prior to that role, she was the founder and chief …See details»
Michael Lilly Obituary - Legacy.com
Apr 9, 2005 Michael LillyMichael Edward Lilly, 50, of Woodbridge died Wednesday, April 6, 2005, at Potomac Hospital.He was preceded in death by his mother, Clare M. Lilly, and his …See details»